Literatur
Collet J‑P, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL et al, ESC Scientific Document Group (2020) 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa575
Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM, TRITON-TIMI 38 Investigators. (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357(20):2001–2015
Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, PLATO Investigators, Freij A, Thorsén M (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045–1057
Sibbing D, Aradi D, Jacobshagen C, Gross L, Trenk D, Geisler T, Orban M, Hadamitzky M, Merkely B, Kiss RG, Komócsi A, Dézsi CA, Holdt L, Felix SB, Parma R, Klopotowski M, Schwinger RHG, Rieber J, Huber K, Neumann FJ, Koltowski L, Mehilli J, Huczek Z, Massberg S, TROPICAL-ACS Investigators (2017) Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial. Lancet 390(10104):1747–1757
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
H. Eggebrecht gibt an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Eggebrecht, H. POPular-Studie: Renaissance von Clopidogrel für ältere Patienten mit Nicht-ST-Hebungsinfarkt?. Kardiologe 14, 463–465 (2020). https://doi.org/10.1007/s12181-020-00428-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12181-020-00428-7